Amwell® (NYSE: AMWL), a national telehealth leader, today announced the general availability of Converge™ for EHRs, adding built in EHR integration capabilities to the Converge platform, alongside the standalone Amwell Now on Converge, which has been deployed in over 40 health systems. Converge is designed to offer a scalable, simple and unified digital care delivery experience across the care continuum. The announcement comes as Amwell’s Converge Platform is named Best New Application in Telehealth by UCSF, a Tech Top 50 by the Massachusetts Technology Leadership Council (MassTLC), and is called out as a driver behind Amwell being named Chilmark Research’s Flagship Vendor in Omnichannel Functionality.
“We are thrilled to see both the industry and our clients responding so favorably to Converge, underscoring broad recognition for our latest platform’s ability to uniquely provide a single, integrated, scalable and dependable platform that combines physical, virtual, and automated care delivery,” said Ido Schoenberg, Chairman and co-CEO, Amwell. “As leaders call for a more streamlined and systemized digital healthcare infrastructure enabled through platform consolidation, these award wins and the general availability of Converge not only illustrate strong momentum for our company, but also bring us one step closer to delivering on our mission to enable greater access to more efficient, more affordable, higher quality care.”
According to a recent survey from Amwell and HIMSS Analytics, 77 percent of hospital and health system leaders want to move toward a single, secure, and fully integrated virtual care platform, and 75 percent of payers say that access to virtual care data and insights through a single digital platform would streamline member experiences, improve patient outcomes, and support the development of innovative models of care coordination and delivery. The Converge Platform is designed to deliver the integrated and unified experience that healthcare leaders are after, providing one complete patient picture that connects and integrates to the entire healthcare ecosystem with a single code base and open architecture, that is simpler and easier to use than ever before.
Amwell has received positive feedback from clients using the Converge Platform following a strong initial rollout.
“Converge makes delivering virtual care quicker and easier. It’s a reliable and stable platform that’s well integrated and enables a seamless virtual handoff between staff and providers, said Michael Williams, Vice President and Chief Information Officer at LMH Health. “The impact extends to our care team as well. One of our family practice providers called the new platform ‘easy-peasy, lemon squeezy’. We are always trying to make life easier for our care teams so when you have a provider saying this, it goes a long way.”
“Converge has provided our clinics with a virtual visit platform designed for healthcare which integrates with the electronic health record for an enhanced patient and clinician experience. We are pleased to partner with Amwell to deliver virtual visits to our patients at the moment this care is needed,” said Deb Muro, Chief Information Officer at El Camino Health.
As a result of the impact Converge is having on the healthcare industry, the Platform has now been recognized with the following awards:
- New Application in Telehealth from the UCSF Health Awards, the premier health tech industry awards. Amwell was recognized for its innovative and scalable telehealth platform scoring high on quality, safety, EHR integrations, cost and convenience.
- Flagship Vendor in Omnichannel Functionality by Chilmark Research, which examined Virtual Care Management overall. Amwell received high marks for strength within the market and is the leader in extensibility and engagement, with Converge being called out for its strength as an omnichannel platform.
- Tech Top 50 Honoree by MassTLC which recognizes the companies, individuals and innovations transforming the Massachusetts technology landscape. Amwell was recognized for its launch and impact of the Converge Platform.
To learn more about Amwell’s Converge Platform and how it can help your organization, visit: https://business.amwell.com/solution-overview/.
Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives. For more information, please visit https://business.amwell.com/.
American Well, Amwell, Converge and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our Form 10-K filed with the SEC on March 26, 2021. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.